WHO ICTRP trial
A prospective, single-center, open-label, randomized controlled phase 2 study to…
KCT0010131 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0010131 |
|---|---|
| Public title | A prospective, single-center, open-label, randomized controlled phase 2 study to evaluate the efficacy of fibrin glue (Greenplast) to prevent post-procedural bleeding after endoscopic submucosal dissection for stomach neoplasms |
| Scientific title | A prospective, single-center, open-label, randomized controlled phase 2 study to evaluate the efficacy of fibrin glue (Greenplast) to prevent post-procedural bleeding after endoscopic submucosal dissection for stomach neoplasms |
| Primary sponsor | Samsung Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Interventions | Drug : Spread the Human fibrinogen concentrate/Aprotinin/Thrombin/Calcium chloride hydrate mixture on iatrogenic ulcer after ESD or not |
| Registration date | Jan 10, 2025 |
| Target size | 252 |
| Registry page | cris.nih.go.kr |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: